Stock Screener App

無料 - Play StoreApp Store

インストールインストール

Dow:

Nasdaq:

S&P 500:

KVUE

$19.311.28%-0.25

Kenvue Inc (KVUE)

Date: O: H: L: C: Vol:

Kenvue Inc (KVUE) 最新ニュース

Kenvue misses third-quarter profit expectations - Investing.com

Kenvue : Quarterly Report for Quarter Ending September 27, 2026 (Form 10-Q) - www.marketscreener.com

Kenvue (KVUE) Surpasses Q3 Earnings Estimates - Zacks Investment Research

Kenvue Q3 2026 Earnings: Self Care Leads Growth as Margins Expand - TradingKey

Kenvue Inc. (KVUE) Misses Q3 EPS by 8c - StreetInsider

Kenvue Reports Third Quarter 2026 Results - Business Wire

Kimberly-Clark closes $4.9B senior notes offering for Kenvue acquisition - StreetInsider

Kimberly-Clark completes $4.9 billion senior notes offering to support Kenvue deal - Investing.com

Kimberly-Clark Raises $4.9 Billion Through Senior Notes Offering for Kenvue Acquisition - TradingView

Kimberly-Clark Corporation (KMB) Closes $4.9B Senior Notes To Fund Kenvue Deal - TradingView

Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch

Kenvue's Q3 Earnings on the Horizon: Key Insights for Investors - TradingView

Kenvue's Q3 Earnings on the Horizon: Key Insights for Investors - Zacks Investment Research

Kenvue earnings ahead: Can profit growth accelerate in Q3? - Investing.com

These consumer staples stocks are trading in overbought territory as earnings season heats up - TradingView

Kimberly-Clark (KMB) Extends Expiration Date of Kenvue Notes Exc - GuruFocus

Kimberly-Clark Corporation Announces Extension of the Expiration Date for Exchange Offers for Kenvue Inc. Notes - marketscreener.com

Dutch Bros vs. Kimberly-Clark: Which Is the Smarter Buy Today? - The Motley Fool

Kimberly-Clark Corporation Announces Extension of the Expiration Date for Exchange Offers for Kenvue Notes - PR Newswire

Kimberly-Clark Corporation (KMB) Extends Kenvue Note Exchange Deadline to Nov. 2 - TradingView

Earnings Preview: Kenvue to Report Financial Results Pre-market on October 30 - Moomoo

Kenvue Inc. Estimates – NYSE:KVUE - TradingView

Kenvue Inc. $KVUE Stock Holdings Trimmed by Assenagon Asset Management S.A. - MarketBeat

Sumitomo Mitsui DS Asset Management Company Ltd Sells 65,441 Shares of Kenvue Inc. $KVUE - MarketBeat

Kenvue Updates Neutrogena Acne Toner Labelling and Safety Information - Global Cosmetics News

Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch

3 Beauty Stocks to Explore as Consumer Preferences Reshape the Market - Zacks Investment Research

Kenvue to Announce Third Quarter 2026 Results on October 30, 2026 - Yahoo Finance

Kenvue Inc. stock falls Wednesday, underperforms market - MarketWatch

Nike vs. Procter & Gamble: Which Consumer Stock Is a Better Buy in 2026? - The Motley Fool

Kenvue Inc. Stock Grades | KVUE - Barron's

Kenvue Inc. Advanced Charts | KVUE - Barron's

Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch

Kimberly-Clark to borrow billions for purchase of Tylenol maker - WFAA

Kimberly-Clark to borrow billions for purchase of Tylenol maker - The Business Journals

Kimberly-Clark (KMB) Prices $4.9 Billion Senior Notes Offering t - GuruFocus

ETFs Are Net Sellers of Kenvue (KVUE) on Oct. 16 - Yahoo Finance

Kimberly-Clark prices $4.9B senior notes across five tranches to fund Kenvue acquisition - TradingView

Kimberly-Clark Prices $4.9 Billion Debt Offering Ahead of Kenvue Deal - marketscreener.com

Kimberly-Clark prices $4.9B senior notes to fund Kenvue acquisition - StreetInsider

Kimberly-Clark prices $4.9 billion debt offering for Kenvue deal By Investing.com - Investing.com India

Kimberly-Clark prices $4.9 billion debt offering for Kenvue deal - Investing.com

Kimberly-Clark Corporation (KMB) Prices $4.9B Notes for Kenvue Deal - TradingView

Kimberly-Clark Corporation Announces Pricing of $4.9 Billion Private Offering of Senior Notes - TradingView

Kenvue Loses Appeal Bid in Tylenol Autism Lawsuits - grafa.com

Kenvue loses bid for rehearing after Tylenol autism lawsuits revived - TradingView

Kimberly-Clark’s Kenvue Buy Clears EU Review After Agreeing To Divest European Tampon Brands - Medtech Insight

Kimberly-Clark Sells Bonds to Help Finance Kenvue Acquisition - marketscreener.com

Kimberly-Clark Offers Bonds to Help Fund Tylenol Maker Takeover - Bloomberg

Kenvue loses bid for rehearing after Tylenol autism lawsuits revived - Reuters

KVUEに類似

KMB$108.680.69%

CHD$110.132.70%

ELF$110.421.14%

IPAR$119.142.38%